This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Isu Abxis Co., Ltd.
Drug Names(s): imiglucerase, ISU302
Abcertin is a CHO cell derived, human macrophage-targeted recombinant human beta-glucocerebrosidase. Its structural, physicochemical, biological, and immunological properties are comparable to the reference product, Cerezyme.
Additional information available to subscribers only: